Veronique Kemmel
Strasbourg, 67085, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment.
Journal: Pharmaceutics
Published: April 02, 2026
Nicotine alters alveolar-barrier integrity by blocking autophagy and occludin trafficking.
Journal: Toxicology
Published: February 17, 2026
Berry e-liquid flavour toxicities are not equal on an alveolar-capillary barrier cell model according to two exposure methods.
Journal: Frontiers in toxicology
Published: December 16, 2025
First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal model.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: November 08, 2025
Delayed Drug-Drug Interaction Between Antiviral Drugs and Tacrolimus in a Pancreatic Islet Transplant Recipient With SARS-CoV-2 Pneumonia.
Journal: Therapeutic drug monitoring
Published: September 24, 2024
Flavoured and nicotine-containing e-liquids impair homeostatic properties of an alveolar-capillary cell model.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 29, 2022
Blood-Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?
Journal: Pharmaceutics
Published: October 09, 2021
New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning.
Journal: Pediatric blood & cancer
Published: March 30, 2020
Intravenous and subcutaneous administration of trastuzumab in a patient on peritoneal dialysis.
Journal: British journal of clinical pharmacology
Published: October 20, 2019
Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach.
Journal: Journal of clinical medicine
Published: August 21, 2019
Last Updated: 09/26/2026